PLOD1 and ovarian hyperstimulation syndrome: Importantly, the IVF community was reluctant to adopt the GnRH agonist trigger in the context of OHSS prevention, since up to the year 2000 GnRH agonists were used solely to prevent premature LH rise and luteinization by pituitary downregulation in most IVF cycles.